American International Group, Inc. Citius Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.6 - $0.9 $3,127 - $4,690	5,212 Added 8.53%	66,297 $59,000
Q4 2023 Feb 13, 2024	SELL	$0.65 - $0.86 $159 - $211	-246 Reduced 0.4%	61,085 $46,000
Q3 2023 Nov 13, 2023	BUY	$0.65 - $1.25 $1,417 - $2,725	2,180 Added 3.69%	61,331 $41,000
Q2 2023 Aug 04, 2023	BUY	$1.08 - $1.65 $63,883 - $97,599	59,151 New	59,151 $70,000
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.87 $54,130 - $115,027	-61,512 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$1.38 - $1.89 $1,609 - $2,203	1,166 Added 1.93%	61,512 $110,000
Q4 2021 Feb 11, 2022	SELL	$1.51 - $2.2 $2,725 - $3,971	-1,805 Reduced 2.9%	60,346 $93,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $2,571 - $3,842	-1,478 Reduced 2.32%	62,151 $126,000
Q2 2021 Aug 13, 2021	BUY	$1.51 - $4.23 $96,079 - $269,150	63,629 New	63,629 $221,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.